A study of the effects of phototherapy dose interval on photobiomodulation of cell cultures

Lasers Surg Med. 2005 Jun;36(5):409-13. doi: 10.1002/lsm.20183.

Abstract

Background and objectives: Dosimetry and treatment frequency are controversial phototherapy issues. Efficacy of dose fractionation on photobiomodulation was evaluated in vitro.

Study design/materials and methods: Human HEP-2 and murine L-929 cell lines were cultured in complete DMEM media. Photoradiation (670 nm, 5 J/cm2/treatment, 50 J/cm2 total energy delivery), was performed varying treatments per 24 hour period: Group I (Controls)-0, Group II-1/d, Group III-2/d, Group IV-4/d. Cell proliferation was measured using Cyquant (fluorescent DNA content) and MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrasolium bromide) assays for 240 hours post therapy. A proliferation index: PI = (#Cells Experimental(t) / #Cells Control(t)) was computed.

Results: MTT assay results demonstrated maximal response in Group III (P < 0.05, n = 3). Cyquant maxima occurred in HEP-2 Groups II and III (P < 0.045) and L-929 Group III (P < 0.091).

Conclusions: Cellular response to dose frequency varies. More frequent treatments (2/24 hours) increased metabolism and proliferation in both cell lines. Further investigation of dose fractionation in phototherapy is warranted.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cell Proliferation / radiation effects*
  • Coloring Agents / pharmacokinetics
  • Connective Tissue Cells / physiology
  • Connective Tissue Cells / radiation effects*
  • Dose Fractionation, Radiation*
  • Epithelial Cells / physiology
  • Epithelial Cells / radiation effects*
  • Humans
  • Mice
  • Phototherapy*
  • Tetrazolium Salts / pharmacokinetics
  • Thiazoles / pharmacokinetics
  • Time Factors

Substances

  • Coloring Agents
  • Tetrazolium Salts
  • Thiazoles
  • thiazolyl blue